Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Jul;14(7):683-686.
doi: 10.1111/crj.13184. Epub 2020 Mar 26.

Characterization and management of elderly and very elderly patients with non-small cell lung cancer

Vera Clérigo  1 , Direndra Hasmucrai  2 , Encarnação Teixeira  2 , Paula Alves  2 , Ana Sofia Vilariça  2 , Renato Sotto-Mayor  2
Affiliations
Observational Study

Characterization and management of elderly and very elderly patients with non-small cell lung cancer

Vera Clérigo et al. Clin Respir J. 2020 Jul.

Abstract

Objectives: Despite non-small cell lung cancer (NSCLC) high prevalence and increasing incidence, evidence specific to the elderly and very elderly is sparse. To retrospectively compare characterization and approach of NSCLC patients (pts) aged 70-79 and ≥80 years.

Methods: We performed a retrospective analysis of 297 adult NSCLC pts who registered and initiated NSCLC management in our Pulmonology Oncology Unit from January 2013 to December 2016 corresponding to 38.2% of all NSCLC patients (n = 778). Demographic data and lung cancer management were analysed.

Results: Pts were categorized as elderly (n = 211, 71.0%) and very elderly (n = 86, 29.0%). Very elderly pts had worse Eastern Cooperative Oncology Group performance status (P = 0.047), higher Charlson age comorbidity index (P < 0.001) and the majority had stage IV cancer (66.3%, P = 0.04). The first management option in very elderly pts was chemotherapy (CTX) (30.2%, P = 0.37) and in elderly pts was multimodal therapy (30.3%, P ≤ 0.001). Support therapy and first-line targeted (EGFR or ALK-positive) were more common in the very elderly (23.6%, P = 0.01; 17.4% P = 0.002, respectively). Curative radiation or surgery rates did not differ between groups. Reasons for premature first-line CTX stop, toxicity and hospitalization did not differ. Death rate (69.7% vs 63.5% for very elderly and elderly, respectively) and mean survival since diagnosis (11.5 vs 11.6 months for very elderly and elderly, respectively) did not differ.

Conclusions: There were significant differences in pts characteristics having the very elderly more multimorbidity and advanced state of disease. First management options were significantly different with respect to multimodal, targeted and support therapy.

Keywords: approach; elderly; non-small cell lung cancer.

PubMed Disclaimer

References

REFERENCES

    1. Siegel R, Jamal A. Cancer Facts and Figures 2017. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts.... Accessed July 1, 2018.
    1. World Health Organization. http://www.who.int/healthinfo/survey/ageingdefnolder/en/. Accessed July 1, 2018.
    1. Früh M, Besrour H, Gillessen S, et al. Management of elderly patients with advanced non-small cell lung cancer: a single-center experience. Chemotherapy. 2013;59:42-50.
    1. Shirvani SM, Jiang J, Chang JY, et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys. 2012;84:1060-1070.
    1. Wisnivesky JP, Smith CB, Packer S, et al. Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages IIIIIA lung cancer: observational cohort study. BMJ. 2011;343:d4013.

Publication types

MeSH terms